Corporate News 27-May-22
Board of Astrazeneca Pharma India recommends Final Dividend
Of Rs.8 per share
Astrazeneca Pharma India announced that the Board of Directors of the Company at its meeting held on 26 May 2022, has recommended a Final dividend of Rs.8 per share (i.e.400%), subject to the approval of the shareholders.
Previous News
Board of Astrazeneca Pharma India recommends final dividend
( Corporate News - 28-May-24 09:52 )
Volumes jump at Astrazeneca Pharma India Ltd counter
( Hot Pursuit - 12-Sep-22 14:30 )
Astrazeneca Pharma soars after receiving regulatory nod for importing Andexxa
( Hot Pursuit - 20-Jan-24 13:14 )
Volumes spurt at AIA Engineering Ltd counter
( Hot Pursuit - 12-Nov-20 11:00 )
Astrazeneca Pharma India standalone net profit rises 236.78% in the June 2019 quarter
( Results - Announcements 07-Aug-19 16:27 )
Astrazeneca Pharma India to announce Quarterly Result
( Corporate News - 30-Jan-21 10:12 )
AstraZeneca announces investment of USD 90 mn in India
( Corporate News - 17-Apr-18 17:58 )
Volumes spurt at Godrej Industries Ltd counter
( Hot Pursuit - 27-May-22 14:30 )
Astrazeneca Pharma India standalone net profit declines 53.97% in the June 2017 quarter
( Results - Announcements 09-Aug-17 17:10 )
AstraZeneca Pharma jumps after strong Q1 earnings
( Hot Pursuit - 10-Aug-16 13:44 )
Astrazeneca Pharma India to announce Quarterly Result
( Corporate News - 01-Nov-22 10:34 )
Other Stories
Tridhya Tech to convene board meeting
03-Jul-24 20:06
Sonu Infratech schedules EGM
03-Jul-24 19:59
Sakuma Exports to convene AGM
03-Jul-24 19:59
Time Technoplast repays commercial paper
03-Jul-24 18:31
Board of Aditya Vision approves stock split and listing of share on NSE
03-Jul-24 18:24
Pricol director resigns
03-Jul-24 18:21
Board of VMS Industries recommends first interim dividend
03-Jul-24 17:49
Lakshmi Machine Works to declare Quarterly Result
03-Jul-24 17:44
Modison to convene AGM
03-Jul-24 17:43
Sybly Industries to discuss results
03-Jul-24 17:43
Back
Top
